KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Total Non-Current Liabilities (2019 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Total Non-Current Liabilities for 6 consecutive years, with $287.7 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities fell 14.59% to $287.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $287.7 million through Dec 2025, down 14.59% year-over-year, with the annual reading at $287.7 million for FY2025, 14.59% down from the prior year.
  • Total Non-Current Liabilities hit $287.7 million in Q4 2025 for Adaptive Biotechnologies, roughly flat from $286.3 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $343.4 million in Q2 2024 to a low of $240.4 million in Q2 2023.
  • Historically, Total Non-Current Liabilities has averaged $295.2 million across 4 years, with a median of $287.7 million in 2025.
  • Biggest five-year swings in Total Non-Current Liabilities: surged 42.85% in 2024 and later decreased 14.59% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $267.2 million in 2022, then fell by 10.01% to $240.4 million in 2023, then surged by 40.13% to $336.9 million in 2024, then dropped by 14.59% to $287.7 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for ADPT at $287.7 million in Q4 2025, $286.3 million in Q3 2025, and $317.1 million in Q2 2025.